| scholarly article | Q13442814 |
| P50 | author | Robert O. Ryan | Q57668754 |
| Vasanthy Narayanaswami | Q95983970 | ||
| P2093 | author name string | Paul S. Hauser | |
| P2860 | cites work | Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles | Q22011017 |
| Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease | Q22248091 | ||
| Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation | Q24291128 | ||
| Behavior of human apolipoprotein E in aqueous solutions and at interfaces | Q24300390 | ||
| Absence of central cholinergic deficits in ApoE knockout mice | Q48664853 | ||
| Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning | Q48668350 | ||
| Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain | Q48744526 | ||
| Severe learning deficits in apolipoprotein E-knockout mice in a water maze task. | Q48759623 | ||
| Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease | Q48795523 | ||
| Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease. | Q48799582 | ||
| A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity | Q48864142 | ||
| The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice | Q48890273 | ||
| Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology | Q49087363 | ||
| Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia | Q49144756 | ||
| Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities | Q49160372 | ||
| Comparison of Lipid-Binding and Lecithin:Cholesterol Acyltransferase Activation of the Amino- and Carboxyl-Terminal Domains of Human Apolipoprotein E3 | Q49167558 | ||
| A monomeric, biologically active, full-length human apolipoprotein E. | Q50928824 | ||
| Regulation of central nervous system cholesterol homeostasis by the liver X receptor agonist TO-901317. | Q51795695 | ||
| Apolipoprotein E knockout mice display procedural deficits in the Morris water maze: analysis of learning strategies in three versions of the task. | Q52010630 | ||
| Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. | Q52016466 | ||
| Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. | Q52051272 | ||
| Cell surface receptor binding of phospholipid . protein complexes containing different ratios of receptor-active and -inactive E apoprotein. | Q52760145 | ||
| No evidence for cholinergic problems in apolipoprotein E knockout and apolipoprotein E4 transgenic mice. | Q53235325 | ||
| Reversal of presynaptic deficits of apolipoprotein E-deficient mice in human apolipoprotein E transgenic mice. | Q53235329 | ||
| Association of apolipoprotein E polymorphism with outcome after head injury. | Q53777504 | ||
| Lipid binding-induced conformational changes in the N-terminal domain of human apolipoprotein E. | Q53940110 | ||
| ApoE as a prognostic factor for post–traumatic coma | Q58451995 | ||
| Apolipoprotein E polymorphism and atherosclerosis | Q68126635 | ||
| Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components | Q68654109 | ||
| Regulation of apolipoprotein E gene expression after injury of the rat sciatic nerve | Q68740798 | ||
| Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins | Q68921833 | ||
| Association of apolipoprotein E with the low density lipoprotein receptor: demonstration of its co-operativity on lipid microemulsion particles | Q69679704 | ||
| The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments | Q70169929 | ||
| The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding | Q70169933 | ||
| Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation | Q70213695 | ||
| Human apolipoprotein E. The complete amino acid sequence | Q70312109 | ||
| Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis | Q70427868 | ||
| Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions | Q70478363 | ||
| The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man | Q70587571 | ||
| Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid | Q70687889 | ||
| Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms | Q70875567 | ||
| Characterization of a unique human apolipoprotein E variant associated with type III hyperlipoproteinemia | Q71133200 | ||
| Reutilization of cholesterol-1,2-H3 in the regeneration of peripheral nerve. An autoradiographic study | Q71484430 | ||
| Type III hyperlipoproteinemia associated with apolipoprotein E deficiency | Q71576154 | ||
| Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid | Q72167723 | ||
| Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification | Q72885840 | ||
| Apolipoprotein E expression by neurons surviving excitotoxic stress | Q73277918 | ||
| Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture | Q73491113 | ||
| Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated | Q73507862 | ||
| Role of lipoproteins in the delivery of lipids to axons during axonal regeneration | Q73919813 | ||
| The lipid-associated conformation of the low density lipoprotein receptor binding domain of human apolipoprotein E | Q74037597 | ||
| The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain | Q74290658 | ||
| Lipid binding-induced conformational change in human apolipoprotein E. Evidence for two lipid-bound states on spherical particles | Q74453728 | ||
| The low density lipoprotein receptor active conformation of apolipoprotein E. Helix organization in n-terminal domain-phospholipid disc particles | Q77332976 | ||
| Pathogenesis of cerebral amyloid angiopathy | Q79196249 | ||
| Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study | Q24319783 | ||
| Apolipoprotein E receptors in the nervous system | Q24607165 | ||
| The LDL receptor | Q24658039 | ||
| Structure of the LDL receptor extracellular domain at endosomal pH | Q27640067 | ||
| Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E | Q27663468 | ||
| Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms | Q27730887 | ||
| Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia | Q27733293 | ||
| Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families | Q27860677 | ||
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| Alzheimer's disease: the cholesterol connection | Q28186482 | ||
| Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins | Q28240446 | ||
| Prediction of protein conformation | Q28240456 | ||
| Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site | Q28264429 | ||
| Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease | Q28265290 | ||
| Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid | Q28279517 | ||
| Apolipoprotein E: cholesterol transport protein with expanding role in cell biology | Q28294791 | ||
| LXRS and FXR: the yin and yang of cholesterol and fat metabolism | Q28295718 | ||
| Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E | Q28508278 | ||
| Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I | Q28565847 | ||
| Uptake of lipoproteins for axonal growth of sympathetic neurons | Q28578928 | ||
| Isoform-specific binding of apolipoprotein E to beta-amyloid | Q28596589 | ||
| Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease | Q29614952 | ||
| Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery | Q29615235 | ||
| Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 | ||
| A receptor-mediated pathway for cholesterol homeostasis | Q29616158 | ||
| Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model | Q29617937 | ||
| Apolipoprotein E4 domain interaction: synaptic and cognitive deficits in mice | Q30486146 | ||
| Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. | Q31452265 | ||
| Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice | Q31735508 | ||
| Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system | Q33262322 | ||
| Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond | Q33702396 | ||
| Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease | Q33732191 | ||
| An optimized negative-staining protocol of electron microscopy for apoE4 POPC lipoprotein | Q33784574 | ||
| Molecular basis of exchangeable apolipoprotein function | Q33796767 | ||
| Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E. | Q37497056 | ||
| Understanding the basis for the association of apoE4 with Alzheimer's disease: opening the door for therapeutic approaches | Q37623844 | ||
| Amphipathic helix motif: classes and properties | Q37987535 | ||
| The carbohydrate content of apoliprotein E from human very low density lipoproteins | Q39579630 | ||
| Apolipoprotein E polymorphism in health and disease | Q39756689 | ||
| Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding | Q39941350 | ||
| Interaction of swine lipoproteins with the low density lipoprotein receptor in human fibroblasts | Q39984968 | ||
| Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins | Q40099596 | ||
| Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts | Q40224633 | ||
| Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration | Q40349274 | ||
| LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. | Q40528558 | ||
| Relation of high-density lipoprotein subfractions and apolipoprotein E isoforms to coronary disease. | Q40564186 | ||
| Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer | Q40571686 | ||
| Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease | Q40621541 | ||
| Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction. | Q40662233 | ||
| The role of apolipoprotein E in the nervous system. | Q40679942 | ||
| Apolipoprotein E: structure-function relationships | Q40737965 | ||
| Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype | Q40817463 | ||
| Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease | Q40849918 | ||
| Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides | Q40879124 | ||
| Apolipoprotein E secretion by macrophages: its potential physiological functions. | Q41235061 | ||
| Human apolipoprotein E: the Alzheimer's disease connection. | Q41239700 | ||
| Amyloid beta-peptide is produced by cultured cells during normal metabolism | Q41602809 | ||
| Differential neurotrophic effects of apolipoprotein E in aged transgenic mice | Q41664893 | ||
| Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. | Q41671941 | ||
| Carboxyl-terminal domain of human apolipoprotein E: expression, purification, and crystallization. | Q41699828 | ||
| Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor | Q41715714 | ||
| Conformational reorganization of the four-helix bundle of human apolipoprotein E in binding to phospholipid | Q41734798 | ||
| Apolipoprotein E: phospholipid binding studies with synthetic peptides containing the putative receptor binding region | Q42034886 | ||
| Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice | Q42045406 | ||
| Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms | Q42173744 | ||
| Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury | Q42456741 | ||
| Apolipoprotein E-deficient mice are not more susceptible to the biochemical and memory deficits induced by nucleus basalis lesion | Q42483912 | ||
| A unified scheme for initiation and conformational adaptation of human apolipoprotein E N-terminal domain upon lipoprotein binding and for receptor binding activity | Q42615768 | ||
| A monomeric human apolipoprotein E carboxyl-terminal domain | Q42625731 | ||
| The epidermal growth factor homology domain of the LDL receptor drives lipoprotein release through an allosteric mechanism involving H190, H562, and H586. | Q42749068 | ||
| Orientation and mode of lipid-binding interaction of human apolipoprotein E C-terminal domain | Q42816401 | ||
| Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. | Q43138847 | ||
| Pyrene fluorescence analysis offers new insights into the conformation of the lipoprotein-binding domain of human apolipoprotein E. | Q43194660 | ||
| apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain | Q43243545 | ||
| Impairment of the blood-nerve and blood-brain barriers in apolipoprotein e knockout mice | Q43581885 | ||
| Essential role for cholesterol in synaptic plasticity and neuronal degeneration | Q43693049 | ||
| CNS synaptogenesis promoted by glia-derived cholesterol | Q43794738 | ||
| Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans | Q43811092 | ||
| Cholesterol's role in synapse formation | Q43929699 | ||
| Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells | Q43931362 | ||
| APOE polymorphism and clinical duration determine regional neuropathology in Swedish APP(670, 671) mutation carriers: implications for late-onset Alzheimer's disease. | Q43982514 | ||
| NMR structure and dynamics of a receptor-active apolipoprotein E peptide | Q44010486 | ||
| Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. | Q44028113 | ||
| Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease. | Q44189963 | ||
| Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation. | Q44251907 | ||
| Effect of domain interaction on apolipoprotein E levels in mouse brain. | Q44267254 | ||
| Lipid binding ability of human apolipoprotein E N-terminal domain isoforms: correlation with protein stability? | Q44368466 | ||
| Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model | Q44412885 | ||
| Lipid-bound Structure of an Apolipoprotein E-derived Peptide | Q44412891 | ||
| Effects of polymorphism on the lipid interaction of human apolipoprotein E. | Q44548874 | ||
| Inter-molecular coiled-coil formation in human apolipoprotein E C-terminal domain | Q44659103 | ||
| Helix orientation of the functional domains in apolipoprotein e in discoidal high density lipoprotein particles | Q44739118 | ||
| A two-module region of the low-density lipoprotein receptor sufficient for formation of complexes with apolipoprotein E ligands | Q44742662 | ||
| Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. | Q44795511 | ||
| ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. | Q44989710 | ||
| Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro | Q45081026 | ||
| Examination of lipid-bound conformation of apolipoprotein E4 by pyrene excimer fluorescence | Q45263580 | ||
| Lipid-induced extension of apolipoprotein E helix 4 correlates with low density lipoprotein receptor binding ability. | Q45930842 | ||
| Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. | Q46001228 | ||
| Interaction with amyloid beta peptide compromises the lipid binding function of apolipoprotein E. | Q46067044 | ||
| Human apolipoprotein E. Receptor binding activity of truncated variants with carboxyl-terminal deletions | Q46118074 | ||
| Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain | Q46175909 | ||
| Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils | Q46212443 | ||
| Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels | Q46262337 | ||
| Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions | Q46398183 | ||
| Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains | Q46421943 | ||
| Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization | Q46474280 | ||
| Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron | Q46505506 | ||
| Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. | Q46529938 | ||
| Age-related congophilic inclusions in the brains of apolipoprotein E-deficient mice. | Q46585768 | ||
| Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. | Q46620615 | ||
| Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution | Q46629889 | ||
| Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins | Q46656933 | ||
| Structural analysis of lipoprotein E particles | Q46698144 | ||
| The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease. | Q46738144 | ||
| Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease | Q46738145 | ||
| Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice | Q46738149 | ||
| Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. | Q46740358 | ||
| Adult mouse astrocytes degrade amyloid-beta in vitro and in situ | Q46779933 | ||
| Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine | Q46797037 | ||
| Is Alzheimer's disease an apolipoprotein E amyloidosis? | Q46974350 | ||
| Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides | Q47349499 | ||
| Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse | Q48024701 | ||
| ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo | Q48087583 | ||
| Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice | Q48095820 | ||
| Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients | Q48146785 | ||
| The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease | Q48254282 | ||
| Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats | Q48256982 | ||
| Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant | Q48390455 | ||
| Synthesis, intracellular processing, and signal peptide of human apolipoprotein E | Q48390623 | ||
| Testing times for the "amyloid cascade hypothesis". | Q48430429 | ||
| ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage | Q48461941 | ||
| Liver X receptor activation restores memory in aged AD mice without reducing amyloid | Q48487098 | ||
| Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition | Q48601482 | ||
| Lipoproteins in the central nervous system | Q33922696 | ||
| Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo | Q33998681 | ||
| Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein | Q33998693 | ||
| Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice | Q34142722 | ||
| Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies | Q34160761 | ||
| Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in transgenic mice | Q34175241 | ||
| Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region | Q34180927 | ||
| Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. | Q34194714 | ||
| Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall | Q34198863 | ||
| Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity | Q34210006 | ||
| Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target | Q34210015 | ||
| Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation | Q34225777 | ||
| Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3 | Q34229659 | ||
| Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids | Q34255552 | ||
| Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors | Q34263181 | ||
| Abnormal in vivo metabolism of apolipoprotein E4 in humans | Q34539465 | ||
| Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system | Q34559847 | ||
| Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease | Q34662682 | ||
| Alzheimer disease therapy: can the amyloid cascade be halted? | Q34828328 | ||
| Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family | Q35023109 | ||
| Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease | Q35084110 | ||
| Genetics of the apolipoprotein E system in man | Q35203817 | ||
| The low-density lipoprotein receptor: ligands, debates and lore | Q35607734 | ||
| Specific regional transcription of apolipoprotein E in human brain neurons | Q35745315 | ||
| Alzheimer disease: mechanistic understanding predicts novel therapies | Q35750804 | ||
| Cerebral lipid deposition in aged apolipoprotein-E-deficient mice | Q35764103 | ||
| Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice | Q35765799 | ||
| Clearing amyloid through the blood-brain barrier | Q35771708 | ||
| Novel action of apolipoprotein E (ApoE): ApoE isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons | Q35808508 | ||
| Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice | Q35809803 | ||
| Role for glia in synaptogenesis | Q35836047 | ||
| Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors | Q35839729 | ||
| Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain | Q35864607 | ||
| Clearance of Alzheimer's Abeta peptide: the many roads to perdition. | Q35875785 | ||
| ApoE deficiency compromises the blood brain barrier especially after injury. | Q35944147 | ||
| Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease | Q36003498 | ||
| The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function | Q36031499 | ||
| The LDL receptor: how acid pulls the trigger | Q36160311 | ||
| Fine structural localization of cholesterol-1,2- 3 H in degenerating and regenerating mouse sciatic nerve | Q36193872 | ||
| Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture | Q36255422 | ||
| Cholesterol and apoe: a target for Alzheimer's disease therapeutics | Q36304886 | ||
| Cholesterol in Alzheimer's disease | Q36317585 | ||
| Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. | Q36383616 | ||
| Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease | Q36412999 | ||
| Nucleotide sequence and structure of the human apolipoprotein E gene | Q36423417 | ||
| Apolipoprotein E structure: insights into function. | Q36527194 | ||
| Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease | Q36604545 | ||
| LRP in amyloid-beta production and metabolism | Q36690854 | ||
| Genetic influences on outcome following traumatic brain injury | Q36753393 | ||
| Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia | Q36857781 | ||
| Apolipoprotein E and cholesterol in aging and disease in the brain | Q37009967 | ||
| Molecular studies of pH-dependent ligand interactions with the low-density lipoprotein receptor | Q37071794 | ||
| Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons | Q37117670 | ||
| Insight on the molecular envelope of lipid-bound apolipoprotein E from electron paramagnetic resonance spectroscopy. | Q37149489 | ||
| Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure | Q37307244 | ||
| Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells | Q37337782 | ||
| The role of calcium in lipoprotein release by the low-density lipoprotein receptor | Q37357958 | ||
| Apolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function | Q37447983 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurobiology | Q2728012 |
| lipid metabolism | Q2792936 | ||
| P304 | page(s) | 62-74 | |
| P577 | publication date | 2010-09-18 | |
| P1433 | published in | Progress in Lipid Research | Q15757018 |
| P1476 | title | Apolipoprotein E: from lipid transport to neurobiology | |
| Apolipoprotein E: From lipid transport to neurobiology | |||
| P478 | volume | 50 |
| Q30402554 | A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions |
| Q37501686 | A novel estrogen-regulated avian apolipoprotein |
| Q42016650 | A potential neuroprotective role of apolipoprotein E-containing lipoproteins through low density lipoprotein receptor-related protein 1 in normal tension glaucoma. |
| Q28085213 | APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective |
| Q36451896 | APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease. |
| Q35064519 | Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry |
| Q50420659 | Age-Related Changes in the Behavior of Apolipoprotein E Knockout Mice. |
| Q35843108 | Age-related differences in memory and executive functions in healthy APOE ɛ4 carriers: the contribution of individual differences in prefrontal volumes and systolic blood pressure |
| Q59357369 | Aging and Apolipoprotein E in HIV Infection |
| Q64060113 | Alzheimer's disease: risk factors and potentially protective measures |
| Q38543425 | Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights |
| Q34616336 | An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach |
| Q58803681 | ApoE Regulates the Development of Adult Newborn Hippocampal Neurons |
| Q39121388 | ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiforme cells |
| Q38008109 | ApoE genotype: from geographic distribution to function and responsiveness to dietary factors |
| Q41203382 | ApoE rs429358 and rs7412 Polymorphism and Gender Differences of Serum Lipid Profile and Cognition in Aging Chinese Population |
| Q46762520 | ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9. |
| Q36602079 | Apolipoprotein E Regulates Injury-Induced Activation of Hippocampal Neural Stem and Progenitor Cells |
| Q38407177 | Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence |
| Q91779698 | Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation |
| Q28249988 | Apolipoprotein E isoforms and lipoprotein metabolism |
| Q30413990 | Apolipoprotein E polymorphisms and severity of cerebral palsy: a cross-sectional study in 255 children in Norway |
| Q89972211 | Apolipoprotein E regulates the maturation of injury-induced adult-born hippocampal neurons following traumatic brain injury |
| Q38197948 | Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease |
| Q35222628 | Apolipoprotein E, carbon dioxide vasoreactivity, and cognition in older adults: effect of hypertension |
| Q38489344 | Apolipoprotein E-dependent differences in innate immune responses of maturing human neuroepithelial progenitor cells exposed to HIV-1. |
| Q30572801 | Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner. |
| Q38435698 | Apolipoprotein E4 Suppresses Neuronal-Specific Gene Expression in Maturing Neuronal Progenitor Cells Exposed to HIV. |
| Q42247507 | Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascade |
| Q48873908 | Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort |
| Q90310484 | Association between APOE polymorphisms and lipid profile in Mexican Amerindian population |
| Q50559366 | Association of White Matter Integrity and Cognitive Functions in Chinese Non-Demented Elderly with the APOE ɛ4 Allele. |
| Q47270627 | Atomistic Insights into Structural Differences between E3 and E4 Isoforms of Apolipoprotein E. |
| Q50553487 | Attentional performance, impulsivity, and related neurotransmitter systems in apoE2, apoE3, and apoE4 female transgenic mice. |
| Q36906438 | BDNF Genotype Interacts with Motor Function to Influence Rehabilitation Responsiveness Poststroke |
| Q41854389 | Biochemical and biophysical characterization of recombinant rat apolipoprotein E: similarities to human apolipoprotein E3. |
| Q42008541 | Blocking the apolipoprotein E/amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology |
| Q30435790 | Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study |
| Q36783549 | Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E. |
| Q90163512 | Cellular Uptake and Clearance of Oxidatively-modified Apolipoprotein E3 by Cerebral Cortex Endothelial Cells |
| Q34669455 | Changes in the proteomic profiles of mouse brain after infection with cyst-forming Toxoplasma gondii |
| Q90637181 | Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay |
| Q52631118 | Class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretion. |
| Q53802856 | Common variants of APOE are associated with anti-epileptic drugs resistance in Han Chinese patients. |
| Q35889289 | Comparative Proteomic Analysis of Two Uveitis Models in Lewis Rats |
| Q39014590 | Dietary DHA and health: cognitive function ageing. |
| Q38075010 | Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB. |
| Q30559265 | Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial |
| Q47125219 | Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides |
| Q43085965 | Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function |
| Q47584760 | Efficient creation of an APOE knockout rabbit |
| Q50972027 | Elevated Levels of LDL-C are Associated With ApoE4 but Not With the rs688 Polymorphism in the LDLR Gene. |
| Q27306763 | Embryonic Medaka Model of Microglia in the Developing CNS Allowing In Vivo Analysis of Their Spatiotemporal Recruitment in Response to Irradiation |
| Q35130903 | FAX1, a novel membrane protein mediating plastid fatty acid export |
| Q42005396 | Fluorescence analysis of the lipid binding-induced conformational change of apolipoprotein E4. |
| Q42174067 | Fluorescence study of domain structure and lipid interaction of human apolipoproteins E3 and E4. |
| Q38007345 | Functional primate genomics--leveraging the medical potential |
| Q30371094 | Gene sequences regulating the production of apoE and cerebral palsy of variable severity. |
| Q30300651 | Genes determining the severity of cerebral palsy: the role of single nucleotide polymorphisms on the amount and structure of apolipoprotein E. |
| Q42323951 | Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry. |
| Q57707722 | How proteomic ApoE serotyping could impact Alzheimer’s disease risk assessment: genetic testing by proteomics |
| Q36539906 | Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo |
| Q39266217 | Human apolipoprotein e resequencing by proteomic analysis and its application to serotyping. |
| Q61809971 | Impact of Apolipoprotein E gene polymorphism during normal and pathological conditions of the brain across the lifespan |
| Q57174487 | Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's disease |
| Q24567759 | Impact of apolipoprotein E on Alzheimer's disease |
| Q50711684 | Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total-Aβ42/Aβ40 ratio. |
| Q33807188 | Influence of domain stability on the properties of human apolipoprotein E3 and E4 and mouse apolipoprotein E. |
| Q38160779 | Innate immune responses to HIV infection in the central nervous system |
| Q36988218 | Interaction of ApoE3 and ApoE4 isoforms with an ITM2b/BRI2 mutation linked to the Alzheimer disease-like Danish dementia: Effects on learning and memory |
| Q47098616 | Interpreting the Mechanism of APOE (p.Leu167del) Mutation in the Incidence of Familial Hypercholesterolemia; An In-silico Approach |
| Q94502431 | Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer's Disease |
| Q36847737 | Links between copper and cholesterol in Alzheimer's disease |
| Q57656679 | Lipidated apolipoprotein E4 structure and its receptor binding mechanism determined by a combined cross-linking coupled to mass spectrometry and molecular dynamics approach |
| Q36682138 | Lipoprotein metabolism in nonalcoholic fatty liver disease |
| Q51748928 | Long-term effects of low-dose mouse liver irradiation involve ultrastructural and biochemical changes in hepatocytes that depend on lipid metabolism. |
| Q34412109 | Longitudinal trajectories of cholesterol from midlife through late life according to apolipoprotein E allele status |
| Q58567981 | Meta-Analysis of the Relationship between the Gene and the Onset of Parkinson's Disease Dementia |
| Q35099780 | Meta-analysis of peripheral blood apolipoprotein E levels in Alzheimer's disease |
| Q36865222 | Molecular mechanisms responsible for the differential effects of apoE3 and apoE4 on plasma lipoprotein-cholesterol levels. |
| Q51095457 | Mouse Models of Alzheimer's Disease. |
| Q36116997 | Multiple loci influencing hippocampal degeneration identified by genome scan |
| Q26771804 | New Drugs from Marine Organisms in Alzheimer's Disease |
| Q39697118 | Nonlinear associations between plasma cholesterol levels and neuropsychological function |
| Q37598119 | Nonlinear longitudinal trajectories of cholesterol and neuropsychological function |
| Q38801607 | Novel susceptibility loci for Alzheimer's disease |
| Q28582464 | Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift |
| Q42704131 | Protective role of the apolipoprotein E2 allele in age-related disease traits and survival: evidence from the Long Life Family Study |
| Q30410253 | Pyrene: a probe to study protein conformation and conformational changes. |
| Q24314295 | Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2 |
| Q46069993 | Retracted: Advances in the physiological and pathological implications of cholesterol. |
| Q56980246 | Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer's disease |
| Q38079285 | Signaling pathways of apoE and its role of gene expression in glomerulus diseases |
| Q46297739 | The Glia-Neuron Lactate Shuttle and Elevated ROS Promote Lipid Synthesis in Neurons and Lipid Droplet Accumulation in Glia via APOE/D. |
| Q91733029 | The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease |
| Q39516222 | The genetic contribution to disease risk and variability in response to diet: where is the hidden heritability? |
| Q34656168 | The relationship between midlife and late life alcohol consumption, APOE e4 and the decline in learning and memory among older adults |
| Q34450271 | The role of apolipoprotein E as a risk factor for an earlier age at onset for Machado-Joseph disease is doubtful |
Search more.